Avalon GloboCare (ALBT) Competitors $2.29 +0.04 (+1.78%) Closing price 10/21/2025 03:59 PM EasternExtended Trading$2.28 -0.01 (-0.44%) As of 06:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALBT vs. TENX, XFOR, SCYX, ANVS, KZR, XCUR, AKTX, TAOX, RNTX, and IMAShould you be buying Avalon GloboCare stock or one of its competitors? The main competitors of Avalon GloboCare include Tenax Therapeutics (TENX), X4 Pharmaceuticals (XFOR), SCYNEXIS (SCYX), Annovis Bio (ANVS), Kezar Life Sciences (KZR), Exicure (XCUR), Akari Therapeutics (AKTX), Synaptogenix (TAOX), Rein Therapeutics (RNTX), and ImageneBio (IMA). These companies are all part of the "pharmaceutical products" industry. Avalon GloboCare vs. Its Competitors Tenax Therapeutics X4 Pharmaceuticals SCYNEXIS Annovis Bio Kezar Life Sciences Exicure Akari Therapeutics Synaptogenix Rein Therapeutics ImageneBio Avalon GloboCare (NASDAQ:ALBT) and Tenax Therapeutics (NASDAQ:TENX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings. Does the media prefer ALBT or TENX? In the previous week, Tenax Therapeutics had 3 more articles in the media than Avalon GloboCare. MarketBeat recorded 3 mentions for Tenax Therapeutics and 0 mentions for Avalon GloboCare. Tenax Therapeutics' average media sentiment score of 0.00 beat Avalon GloboCare's score of 0.00 indicating that Tenax Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Avalon GloboCare Neutral Tenax Therapeutics Neutral Do insiders & institutionals hold more shares of ALBT or TENX? 1.4% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 1.7% of Tenax Therapeutics shares are owned by institutional investors. 37.3% of Avalon GloboCare shares are owned by insiders. Comparatively, 3.7% of Tenax Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is ALBT or TENX more profitable? Tenax Therapeutics has a net margin of 0.00% compared to Avalon GloboCare's net margin of -1,451.94%. Avalon GloboCare's return on equity of 0.00% beat Tenax Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Avalon GloboCare-1,451.94% N/A -75.12% Tenax Therapeutics N/A -31.34%-30.39% Do analysts prefer ALBT or TENX? Tenax Therapeutics has a consensus price target of $18.00, suggesting a potential upside of 149.31%. Given Tenax Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Tenax Therapeutics is more favorable than Avalon GloboCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avalon GloboCare 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Tenax Therapeutics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.83 Which has preferable valuation & earnings, ALBT or TENX? Avalon GloboCare has higher revenue and earnings than Tenax Therapeutics. Tenax Therapeutics is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvalon GloboCare$1.33M6.61-$7.90M-$19.96-0.11Tenax TherapeuticsN/AN/A-$17.60M-$0.92-7.85 Which has more risk & volatility, ALBT or TENX? Avalon GloboCare has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500. Comparatively, Tenax Therapeutics has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. SummaryTenax Therapeutics beats Avalon GloboCare on 11 of the 16 factors compared between the two stocks. Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALBT vs. The Competition Export to ExcelMetricAvalon GloboCareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.63M$3.47B$6.22B$10.67BDividend YieldN/A2.27%5.74%4.88%P/E Ratio-0.1123.0629.1527.23Price / Sales6.61494.28589.23132.71Price / CashN/A47.5937.5161.65Price / Book-0.2010.6612.386.59Net Income-$7.90M-$52.56M$3.32B$276.14M7 Day Performance2.23%2.64%0.75%-0.72%1 Month Performance-16.12%13.86%7.29%2.47%1 Year Performance-22.90%14.85%62.62%33.90% Avalon GloboCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALBTAvalon GloboCare0.9424 of 5 stars$2.29+1.8%N/A-23.7%$8.63M$1.33M-0.115TENXTenax Therapeutics2.0573 of 5 stars$7.47+0.8%$18.00+141.0%+78.3%$34.06MN/A-8.129Short Interest ↑XFORX4 Pharmaceuticals3.9847 of 5 stars$2.96-3.3%$34.17+1,054.3%-78.9%$33.89M$2.56M-0.2080SCYXSCYNEXIS0.7264 of 5 stars$0.80-1.1%N/A-48.7%$33.28M$3.75M-1.9860Short Interest ↑High Trading VolumeANVSAnnovis Bio3.3218 of 5 stars$1.70+2.1%$17.33+922.6%-77.5%$33.13MN/A-0.833KZRKezar Life Sciences2.6456 of 5 stars$4.40+2.4%$9.00+104.8%-21.4%$32.17M$7M-0.4560XCURExicure1.2183 of 5 stars$5.08-1.3%N/A+77.5%$32.07M$500K-1.3150News CoverageAKTXAkari Therapeutics2.6939 of 5 stars$0.96+2.2%$3.30+242.7%-65.2%$31.41MN/A0.009Short Interest ↑TAOXSynaptogenix0.0809 of 5 stars$8.95-6.2%N/AN/A$31.24MN/A-0.444Gap UpRNTXRein Therapeutics2.6564 of 5 stars$1.33+0.8%$10.00+651.9%N/A$31.00MN/A-0.499IMAImageneBio2.8655 of 5 stars$7.64-0.7%$35.50+364.7%-63.1%$30.64M$9.16M-0.9970Negative NewsShort Interest ↑ Related Companies and Tools Related Companies Tenax Therapeutics Competitors X4 Pharmaceuticals Competitors SCYNEXIS Competitors Annovis Bio Competitors Kezar Life Sciences Competitors Exicure Competitors Akari Therapeutics Competitors Synaptogenix Competitors Rein Therapeutics Competitors ImageneBio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALBT) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalon GloboCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
